Skip Navigation

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow E-Letters: Submit a response to the article
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (7)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Sewell, J. C.
Right arrow Articles by Sear, J. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sewell, J. C.
Right arrow Articles by Sear, J. W.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

British Journal of Anaesthesia, 2002, Vol. 88, No. 2 166-174
© 2002 The Board of Management and Trustees of the British Journal of Anaesthesia


Clinical Investigations

Can molecular similarity-activity models for intravenous general anaesthetics help explain their mechanism of action?

J. C. Sewell1 and J. W. Sear*,2

1Department of Biosciences, University of Hertfordshire, College Lane, Hatfield, Hertfordshire AL10 9AB and 2Nuffield Department of Anaesthetics, University of Oxford, John Radcliffe Hospital, Headington, Oxford OX3 9DU, UK*Corresponding author

Background. The importance of molecular shape and electrostatic potential in determining the activities of 11 structurally-diverse i.v. general anaesthetics was investigated using computational chemistry techniques.

Methods. The free plasma anaesthetic concentrations that abolished the response to noxious stimulation were obtained from the literature. The similarities in the molecular shapes and electrostatic potentials of the agents to eltanolone (the most potent anaesthetic agent in the group) were calculated using Carbo indices, and correlated with in vivo potency.

Results. The best model obtained was based on the similarities of the anaesthetics to two eltanolone conformers (r2=0.820). This model correctly predicted the potencies of the R- and S-enantiomers of ketamine, but identified alphaxalone as an outlier. Exclusion of alphaxalone substantially improved the activity correlation (r2=0.972). A bench mark model based on octanol/water partition coefficients (r2=0.647) failed to predict the potency order of the ketamine enantiomers.

Conclusions. The results demonstrate that a single activity model can be formulated for chiral and non-chiral i.v. anaesthetic agents using molecular similarity indices.

Br J Anaesth 2002; 88: 166–74


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Br J AnaesthHome page
J. W. Sear
What makes a molecule an anaesthetic? Studies on the mechanisms of anaesthesia using a physicochemical approach
Br. J. Anaesth., July 1, 2009; 103(1): 50 - 60.
[Abstract] [Full Text] [PDF]


Home page
Br J AnaesthHome page
D. Turina, V. M. Loitto, K. Bjornstrom, T. Sundqvist, and C. Eintrei
Propofol causes neurite retraction in neurones
Br. J. Anaesth., September 1, 2008; 101(3): 374 - 379.
[Abstract] [Full Text] [PDF]


Home page
Br J AnaesthHome page
M. Haines, L. M. Mao, L. Yang, A. Arora, E. E. Fibuch, and J. Q. Wang
Modulation of AMPA receptor GluR1 subunit phosphorylation in neurons by the intravenous anaesthetic propofol
Br. J. Anaesth., May 1, 2008; 100(5): 676 - 682.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
L. J. Voss, G. Ludbrook, C. Grant, R. Upton, and J. W. Sleigh
A Comparison of Pharmacokinetic/Pharmacodynamic versus Mass-Balance Measurement of Brain Concentrations of Intravenous Anesthetics in Sheep
Anesth. Analg., June 1, 2007; 104(6): 1440 - 1446.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
J. C. Sewell and J. W. Sear
Determinants of volatile general anesthetic potency: a preliminary three-dimensional pharmacophore for halogenated anesthetics.
Anesth. Analg., March 1, 2006; 102(3): 764 - 771.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
J. C. Sewell and J. W. Sear
Derivation of Preliminary Three-Dimensional Pharmacophores for Nonhalogenated Volatile Anesthetics
Anesth. Analg., September 1, 2004; 99(3): 744 - 751.
[Abstract] [Full Text] [PDF]


Home page
Br J AnaesthHome page
J. C. Sewell and J. W. Sear
Derivation of preliminary three-dimensional pharmacophoric maps for chemically diverse intravenous general anaesthetics{dagger}
Br. J. Anaesth., January 1, 2004; 92(1): 45 - 53.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.